Q-Sera has the support of leading Australian Investors, Uniseed and the Medical Research Commercialization Fund (MRCF).
UniQuest is Australia’s leading university commercializing entity, managing the intellectual property of The University of Queensland. It benchmarks in the top 10 percent globally for university-based technology transfer offices. UniQuest and its spin-out companies have raised more than A$630 million to help take UQ technologies to market and returned more than A$435 million in revenue to UQ. Since 2007, gross sales of products using UQ technology licensed by UniQuest total more than $16 billion. Among others, UniQuest was responsible for commercializing the HPV vaccine Gardasil®, the Triple P Positive Parenting Program, the imaging technology used in two-thirds of the world’s MRI machines, and a potential new treatment for pain through spin-out company Spinifex Pharmaceuticals Pty Ltd – one of Australia’s largest ever biotech acquisitions. For more information, visit www.uniquest.com.au.